FdaApplication

ANDA 203315

Back to search

Identifiers

Properties

PropertyValue
applicant_nameRISING PHARMA HOLDINGS INC
application_typeANDA
approval_date2017-03-10

Products (1)

ProductActive ingredientStrengthDosage form
EXEMESTANEEXEMESTANE25MGTABLET;ORAL

1 product